Avience Biomedicals IPO: Strong Debut Expected as GMP Hits 62% Premium
Avience Biomedicals IPO: Strong Debut Expected as GMP Hits 62% Premium Avience Biomedicals is poised for a blockbuster entry onto the NSE SME platform this Thursday, backed by mas…